Tuesday, February 10, 2026
ADVT 
International

17 dead, 24 wounded in school shooting in Russia

Darpan News Desk The Canadian Press, 26 Sep, 2022 04:06 PM
  • 17 dead, 24 wounded in school shooting in Russia

MOSCOW (AP) — A gunman opened fire in a school in central Russia on Monday, killing 17 people and wounding 24 others before shooting himself dead, authorities said.

The shooting took place in School No. 88 in Izhevsk, a city 960 kilometers (600 miles) east of Moscow in the Udmurtia region.

Russia’s Investigative Committee identified the gunman as 34-year-old Artyom Kazantsev, a graduate of the same school, and said he was wearing a black t-shirt bearing “Nazi symbols.” No details about his motives have been released.

The government of Udmurtia said 17 people, including 11 children, were killed in the shooting. According to Russia's Investigative Committee, 24 other people, including 22 children, were wounded in the attack.

The governor of Udmurtia, Alexander Brechalov, said the gunman, who he said was registered as a patient at a psychiatric facility, killed himself after the attack.

Kremlin spokesman Dmitry Peskov described the shooting as “a terrorist act” and said Russian President Vladimir Putin has given all the necessary orders to the relevant authorities.

“President Putin deeply mourns deaths of people and children in the school, where a terrorist act took place,” Peskov told reporters Monday.

The school educates children between grades one and 11. It has been evacuated and the area around it has been cordoned off, the governor said.

Russia's National Guard said Kazantsev used two non-lethal handguns adapted to fire real bullets. The guns were not registered with the authorities.

A criminal probe into the incident has been launched on charges of multiple murder and illegal possession of firearms.

Izhevsk, a city of 640,000, is located west of the Ural mountains in central Russia.

MORE International ARTICLES

Trump supporters mass in D.C. as Biden era begins

Trump supporters mass in D.C. as Biden era begins
Several Republican lawmakers will formally object to president-elect Joe Biden's win, citing phoney allegations of election fraud — a futile exercise that will likely do little beyond delaying the inevitable.

Trump supporters mass in D.C. as Biden era begins

Fauci: US could soon give 1 million vaccinations a day

Fauci: US could soon give 1 million vaccinations a day
Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Fauci: US could soon give 1 million vaccinations a day

Trump call ratchets up political tension in U.S.

Trump call ratchets up political tension in U.S.
That demand is sure to reverberate Tuesday, when two run-off elections in Georgia will decide whether Democrats or Republicans control the Senate.

Trump call ratchets up political tension in U.S.

'Relieved': US health workers start getting COVID-19 vaccine

'Relieved': US health workers start getting COVID-19 vaccine
Shipments of precious frozen vials of vaccine made by Pfizer Inc. and its German partner BioNTech began arriving at hospitals around the country Monday.

'Relieved': US health workers start getting COVID-19 vaccine

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent